Intra-Cellular Therapies Overview

Intra-Cellular Therapies Gross Profit

Gross Profit analysis for ITCI.

Quarterly Gross Profit

$178.82M

↑ 48.02% YoY

As of Dec 31, 2024

Annual Gross Profit (TTM)

$623.67M

↑ 45.57% YoY

Trailing 12 months ending Dec 31, 2024

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin